hypertension

hypertension

Episode 228: PREMIUM – The new JNC8 high blood pressure guidelines dissected and exposed

In episode 228, Mike and James deconstruct the most recent JNC 8 high blood pressure guidelines. We discuss what is good and bad and we debate the issues and what the changes might mean for practice. Read more »

Episode 207: Please stop measuring all those blood pressures – PART II

In episode 207, Mike and James keep up the pressure on blood pressure measurements. We talk about the magnitude of the benefit, the variability of all these measurements and get into the whole starting and stopping approach. At the end of the podcast we decide the bottom line is to not panic, sit back, put up your feet and relax and try to get your patients to do the same thing. Read more »

Episode 191: A New Year brings new questions and some new but mainly old answers – PART III

In episode 191, Mike and James finally get to the end of the latest listener questions. We try our best to answer issues about niacin, insulin, COPD, hypertension and most importantly sputum color. At the end we also question the questioner’s questions, which leads us to even more questioning. Read more »

Episode 158: You say chlorthalidone I say hydrochlorothiazide

In episode 158, Mike and James work under very distressing conditions (no microphones, colds, Bubonic plague) and discuss the issue of which thiazide should you choose. Evidence, personal experience and values swirl continually through the diatribe. Read more »

Episode 146: PREMIUM Two potentially practice changing studies

In episode 146, a PREMIUM podcast, Mike and James talk about some timely studies. Mike discusses some interesting results from a study that looked at the simple intervention of taking antihypertensives at bedtime and we find out that this intervention not only has an impact on blood pressure but also produces a further reduction in cardiovascular events. Read more »

Episode 142: Polypharmacy - a pollyanna approach to a polymorphic problem - Part III

In episode 142, Mike and James finish off the elderly, but hopefully not literally, by discussing some key RCTs that help inform us as to a few medications that likely should be part of your discussion/armamentarium with your elderly patients. At the end Mike extols the virtues of low doses and James tells him I told you so.

Show notes Read more »

Episode 102: Blood pressure targets: Bullseye or Bulls--t

In episode 102, Mike and James, with laser precision, look at the evidence around blood pressure targets. We cover data in non-diabetics, diabetics, chronic kidney disease and the elderly. At the end they agree that the BP target we used 30 years ago (140/90) is still pretty good. Read more »

Syndicate content